Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Pregnancy Tests × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Spondylarthritis 1 Precancerous Conditions 1 Papillomavirus Infections 1 Neuroblastoma 1 Neoplasms by Site 1 Myelodysplastic Syndromes 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Genital Diseases 1 Female Urogenital Diseases and Pregnancy Complications 1

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 3-Iodobenzylguanidine 32 Cisplatin 28 Granulocyte Colony-Stimulating Factor 27 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 dinutuximab 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 naxitamab 14 humanized 3F8 anti-GD2 monoclonal antibody 14 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Biopsy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780128 2026-03-10

NEPENTHE

Children's Hospital of Philadelphia

Phase 1 Terminated

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡